Anbio Biotechnology Statistics
Total Valuation
NNNN has a market cap or net worth of $296.05 million. The enterprise value is $281.65 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NNNN has 43.89 million shares outstanding. The number of shares has increased by 97.30% in one year.
Current Share Class | 43.89M |
Shares Outstanding | 43.89M |
Shares Change (YoY) | +97.30% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 39.69M |
Valuation Ratios
The trailing PE ratio is 114.60.
PE Ratio | 114.60 |
Forward PE | n/a |
PS Ratio | 33.22 |
Forward PS | n/a |
PB Ratio | 15.82 |
P/TBV Ratio | 17.07 |
P/FCF Ratio | n/a |
P/OCF Ratio | 141.04 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 118.70 |
EV / Sales | 34.41 |
EV / EBITDA | n/a |
EV / EBIT | 141.15 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.71
Current Ratio | 10.71 |
Quick Ratio | 7.41 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.83% and return on invested capital (ROIC) is 7.79%.
Return on Equity (ROE) | 14.83% |
Return on Assets (ROA) | 7.18% |
Return on Invested Capital (ROIC) | 7.79% |
Return on Capital Employed (ROCE) | 11.61% |
Revenue Per Employee | $303,154 |
Profits Per Employee | $87,883 |
Employee Count | 27 |
Asset Turnover | 0.47 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 6.81 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 53.43 |
Average Volume (20 Days) | 29,741 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NNNN had revenue of $8.19 million and earned $2.37 million in profits. Earnings per share was $0.06.
Revenue | 8.19M |
Gross Profit | 5.89M |
Operating Income | 2.00M |
Pretax Income | 4.33M |
Net Income | 2.37M |
EBITDA | n/a |
EBIT | 2.00M |
Earnings Per Share (EPS) | $0.06 |
Full Income Statement Balance Sheet
The company has $11.76 million in cash and n/a in debt, giving a net cash position of $11.76 million or $0.27 per share.
Cash & Cash Equivalents | 11.76M |
Total Debt | n/a |
Net Cash | 11.76M |
Net Cash Per Share | $0.27 |
Equity (Book Value) | 17.19M |
Book Value Per Share | 0.41 |
Working Capital | 16.80M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 2.08M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 71.90%, with operating and profit margins of 24.38% and 28.99%.
Gross Margin | 71.90% |
Operating Margin | 24.38% |
Pretax Margin | 28.99% |
Profit Margin | 28.99% |
EBITDA Margin | n/a |
EBIT Margin | 24.38% |
FCF Margin | n/a |